Literature DB >> 2573000

Selectivity of various opioid peptides towards delta-, kappa; and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain.

A H Mulder1, G Wardeh, F Hogenboom, A L Frankhuyzen.   

Abstract

The selectivity of a series of opioid peptides towards the mu-, delta- and kappa-opioid receptors mediating differential inhibition of electrically-induced neurotransmitter release from rat brain slices was studied, viz. cortical [3H]noradrenaline release (inhibited via mu-receptors), striatal [3H]dopamine release (inhibited via kappa-receptors) and striatal [14C] acetylcholine release (inhibited via delta-receptors). The highest affinity pD2 7.4) and selectivity towards mu-receptors was exhibited by Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol (DAGO), whereas [D-Pen2, D-Pen5]enkephalin (DPDPE) was found to be the most selective delta-receptor agonist (pD2 7.3). Also the hexapeptides [D-Ser2]Leu-enkephalin-Thr (DSLET) and [D-Thr2]Leu-enkephalin-Thr (DTLET) showed a relatively high selectivity and, in addition, a high affinity (pD2 8.2-8.4) for delta-opioid receptors. Both dynorphin(1-13) and dynorphin(1-8) exhibited a high affinity for kappa-receptors (pD2 resp. 8.3 and 8.0), but the latter was far less selective. Both of the dynorphin A-related peptides showed affinity to mu-receptors (pD2 6.7-6.8), but dynorphin(1-8), in contrast to dynorphin(1-13), also displayed a high affinity to delta-receptors (pD2 7.6).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573000     DOI: 10.1016/0143-4179(89)90065-6

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.

Authors:  A H Mulder; D M Burger; G Wardeh; F Hogenboom; A L Frankhuyzen
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

2.  Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.

Authors:  A L Svingos; E E Colago; V M Pickel
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

3.  Differences in dopamine and opioid receptor ratios in the nucleus accumbens relate to physical contact and undirected song in pair-bonded zebra finches.

Authors:  Sarah J Alger; Sharon A Stevenson; Ana Armenta Vega; Cynthia A Kelm-Nelson; Charity Vilchez Juang; Lauren V Riters
Journal:  Behav Neurosci       Date:  2021-10-07       Impact factor: 1.912

4.  Stimulus-evoked release of tritiated monoamines from rat periaqueductal gray slices in vitro and its receptor-mediated modulation.

Authors:  D H Versteeg; T Csikós; H Spierenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

5.  Direct inhibition of hypothalamic proopiomelanocortin neurons by dynorphin A is mediated by the μ-opioid receptor.

Authors:  Reagan L Pennock; Shane T Hentges
Journal:  J Physiol       Date:  2014-08-01       Impact factor: 5.182

6.  Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.

Authors:  H Bachelard; M Pître
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

7.  G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons.

Authors:  Jo-Hao Ho; Edward L Stahl; Cullen L Schmid; Sarah M Scarry; Jeffrey Aubé; Laura M Bohn
Journal:  Sci Signal       Date:  2018-08-07       Impact factor: 8.192

8.  Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus.

Authors:  B A S Reyes; Charles Chavkin; E J van Bockstaele
Journal:  J Comp Neurol       Date:  2009-01-20       Impact factor: 3.215

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.